These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7581695)

  • 1. Molecular modeling of antibody-combining sites.
    Webster DM; Rees AR
    Methods Mol Biol; 1995; 51():17-49. PubMed ID: 7581695
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulin structure.
    Virella G; Wang AC
    Immunol Ser; 1993; 58():75-90. PubMed ID: 8424994
    [No Abstract]   [Full Text] [Related]  

  • 3. Catalytic antibody model and mutagenesis implicate arginine in transition-state stabilization.
    Roberts VA; Stewart J; Benkovic SJ; Getzoff ED
    J Mol Biol; 1994 Jan; 235(3):1098-116. PubMed ID: 8289310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling of an anti-DNA autoantibody (V-88) and mapping of its V region epitopes recognized by heterologous and autoimmune antibodies.
    Hobby P; Ward FJ; Denbury AN; Williams DG; Staines NA; Sutton BJ
    J Immunol; 1998 Sep; 161(6):2944-52. PubMed ID: 9743357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the antigen combining site of an anti-dinitrophenyl antibody, ANO2.
    Bassolino-Klimas D; Bruccoleri RE; Subramaniam S
    Protein Sci; 1992 Nov; 1(11):1465-76. PubMed ID: 1303765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
    Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L
    J Mol Biol; 1996 Jun; 259(5):957-69. PubMed ID: 8683598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis and prediction of VH/VL packing in antibodies.
    Abhinandan KR; Martin AC
    Protein Eng Des Sel; 2010 Sep; 23(9):689-97. PubMed ID: 20591902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
    Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
    Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity maturation increases the stability and plasticity of the Fv domain of anti-protein antibodies.
    Acierno JP; Braden BC; Klinke S; Goldbaum FA; Cauerhff A
    J Mol Biol; 2007 Nov; 374(1):130-46. PubMed ID: 17916365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-chain anti-DNA FV.
    Polymenis M; Stollar BD
    Methods Mol Biol; 1995; 51():265-79. PubMed ID: 7581703
    [No Abstract]   [Full Text] [Related]  

  • 16. A mutational analysis of the binding of two different proteins to the same antibody.
    Dall'Acqua W; Goldman ER; Eisenstein E; Mariuzza RA
    Biochemistry; 1996 Jul; 35(30):9667-76. PubMed ID: 8703938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody scFv fragments without disulfide bonds made by molecular evolution.
    Proba K; Wörn A; Honegger A; Plückthun A
    J Mol Biol; 1998 Jan; 275(2):245-53. PubMed ID: 9466907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a human VH: requirements for maintaining a monomeric fragment.
    Dottorini T; Vaughan CK; Walsh MA; LoSurdo P; Sollazzo M
    Biochemistry; 2004 Jan; 43(3):622-8. PubMed ID: 14730966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.